Publication: Safety and efficacy of ponatinib in real world clinical practice. Results from the Spanish Compassionate Use Program. A GELMC study
dc.contributor.author | Valentin, GG | |
dc.contributor.author | Hernandez-Boluda, JC | |
dc.contributor.author | Osorio, S | |
dc.contributor.author | Correa, JG | |
dc.contributor.author | Sanchez-Guijo, F | |
dc.contributor.author | Gómez-Casares, MT | |
dc.contributor.author | Durán, S | |
dc.contributor.author | Portero, MA | |
dc.contributor.author | Boqué, C | |
dc.contributor.author | Pérez-Encinas, M | |
dc.contributor.author | Mata, MI | |
dc.contributor.author | Romo, MA | |
dc.contributor.author | Vallansot, R | |
dc.contributor.author | Payer, A | |
dc.contributor.author | Noya, MS | |
dc.contributor.author | Caballero, G | |
dc.contributor.author | Ramirez Sánchez, MJ | |
dc.contributor.author | Jimenez-Velasco, A | |
dc.contributor.author | Steegmann, JL | |
dc.contributor.authoraffiliation | [Valentin,GG] Servicio de Hematología, Hospital Universitario Ramón y Cajal, Madrid. [Hernández-Boluda,JC] Servicio de Hematología, Hospital Clínico, Valencia. [Osorio,S] Servicio de Hematología, Hospital Universitario Gregorio Marañon, Madrid. [Correa,JG] Servicio de Hematología, Hospital Clinic, Barcelona. [Sanchez-Guijo,F] Servicio de Hematología, Hospital Universitario de Salamanca, Salamanca. [Gómez-Casares,MT] Servicio de Hematología, Hospital Universitario Dr Negrin, Gran Canaria. [Durán,S] Servicio de Hematología, Hospital Médico Quirúrgico de Jaen, Jaen. [Portero,MA] Servicio de Hematología, Hospital Universitario Virgen Macarena, Sevilla. [Boqué,C] Servicio de Hematología, ICO-Hospital Duran I Reynals. Hospitaletdel Llobregat, Barcelona. [Pérez-Encinas,M] Servicio de Hematología, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela. [Mata,MI] Servicio de Hematología, Hospital Costa del Sol, Marbella, Málaga. [Romo,MA] Servicio de Hematología, Hospital Meixoeiro, Vigo, Vigo. [Vallansot,R] Servicio de Hematología, Hospital Juan XXIII, Tarragona. [Payer,A] Servicio de Hematología, Hospital Universitario Central de Asturias, Oviedo. [Noya,MS] Servicio de Hematología, Complejo Hospitalario Universitario A Coruña, La Coruña. [Caballero,G] Servicio de Hematologia, Hospital Universitario Miguel Servet, Zaragoza. [Ramirez Sánchez,MJ] Servicio de Hematologia, Hospital del SAS de Jérez de la Frontera, Cádiz. [Jimenez-Velasco,A] Servicio de Hematologia, Servicio de Hematología, Hospital Regional Universitario Carlos Haya, Málaga. [Steemann,JL] Servicio de Hematología y IIS-IP, Hospital Universitario de la Princesa, Madrid, Spain. | es |
dc.date.accessioned | 2016-10-03T10:11:29Z | |
dc.date.available | 2016-10-03T10:11:29Z | |
dc.date.issued | 2016-06 | |
dc.description.abstract | Aims: The purpose of this study is to provide safety and efficacy information from patients treated with ponatinib in real world clinical practice. | es |
dc.description.version | No | es |
dc.identifier.citation | Valentin GG, Hernandez-Boluda JC, Osorio S, Correa JG, Sanchez-Guijo F, Gómez-Casares MT, et al.Safety and efficacy of ponatinib in real world clinical practice. Results from the Spanish Compassionate Use Program. A GELMC study. Haematologica. 2016; 101 (s1) PB1832 | es |
dc.identifier.essn | 1592-8721 | |
dc.identifier.issn | 0390-6078 | |
dc.identifier.uri | http://hdl.handle.net/10668/2441 | |
dc.journal.title | Haematologica | |
dc.language.iso | en | |
dc.organization | AGS Jerez, Costa Noroeste y Sierra de Cádiz | |
dc.publisher | Ferrata Storti Foundation | es |
dc.relation.publisherversion | http://www.haematologica.org/content/101/s1 | es |
dc.rights.accessRights | open access | |
dc.subject | Humanos | es |
dc.subject | Imidazoles | es |
dc.subject | Leucemia mielogenosa crónica BCR-ABL positiva | es |
dc.subject | Piridacinas | es |
dc.subject | Riesgo | es |
dc.subject.mesh | Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans | es |
dc.subject.mesh | Medical Subject Headings::Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds, 1-Ring::Azoles::Imidazoles | es |
dc.subject.mesh | Medical Subject Headings::Diseases::Hemic and Lymphatic Diseases::Hematologic Diseases::Bone Marrow Diseases::Myeloproliferative Disorders::Leukemia, Myelogenous, Chronic, BCR-ABL Positive | es |
dc.subject.mesh | Medical Subject Headings::Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds, 1-Ring::Pyridazines | es |
dc.subject.mesh | Medical Subject Headings::Health Care::Health Care Quality, Access, and Evaluation::Quality of Health Care::Health Care Evaluation Mechanisms::Statistics as Topic::Probability::Risk | es |
dc.title | Safety and efficacy of ponatinib in real world clinical practice. Results from the Spanish Compassionate Use Program. A GELMC study | es |
dc.type | conference presentation | |
dc.type.hasVersion | VoR | |
dspace.entity.type | Publication |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- ValentinGG_SafetyAndEfficacyOfPonatinib.pdf
- Size:
- 85.12 KB
- Format:
- Adobe Portable Document Format
- Description:
- Abstract